US87410C1045 - Common Stock
TALARIS THERAPEUTICS INC
NASDAQ:TALS (10/19/2023, 7:10:51 PM)
After market: 2.75 +0.03 (+1.1%)2.72
-0.02 (-0.73%)
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company is headquartered in Louisville, Kentucky and currently employs 129 full-time employees. The company went IPO on 2021-05-07. The firm is engaged in developing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The firm is advancing a pipeline of programs across three therapeutic categories: solid organ transplantation, severe autoimmune disease, and severe non-malignant blood, immune and metabolic disorders. Its therapeutic approach, allo-HSCT therapy prevents organ rejection without the morbidity and mortality that has been associated with the use of anti-rejection medicines, also known as chronic immunosuppression. Allo-HSCT is used to replace diseased immune, blood or stem cells in patients with severe immune, blood or metabolic disorders. The Company’s lead product candidate, FCR001, which is central to its Facilitated Allo-HSCT Therapy, is an allogeneic cell therapy comprised of stem and immune cells that are procured from a healthy donor, who is also the organ donor in the case of organ transplantation.
TALARIS THERAPEUTICS INC
570 Preston St., Suite 400
Louisville KENTUCKY
P: 15023989250.0
CEO: Scott Requadt
Employees: 129
Website: https://talaristx.com/
Talaris Therapeutics shareholders have approved a merger with Tourmaline Bio and a 1-for-10 reverse stock split to be conducted just prior to the closing. Read more here.
Combined Company to Trade on Nasdaq Under Ticker “TRML”Talaris Announces 1-for-10 Reverse Stock Split of Common Stock BOSTON, Oct. 17, 2023 (GLOBE...
Special dividend estimated to be $1.5118 per share Payment of special dividend conditioned upon closing of merger, which is subject to stockholder...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Here you can normally see the latest stock twits on TALS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: